StockData
IGC Pharma, Inc. logo

IGC Pharma, Inc. (IGC) stock

IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/3011% above fair value
$0.19+0.01 (+7.37%)

Close on Nov 17, 2026Market cap $19.43MP/E –Yield –

IGC Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for IGC Pharma

IGC Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More IGC Pharma figures

See a number that looks wrong?